Barclays PLC Bio Affinity Technologies, Inc. Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Barclays PLC holds 3,181 shares of BIAF stock, worth $954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,181Holding current value
$954% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
18Shares Held
522KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA177KShares$53,0690.0% of portfolio
-
Geode Capital Management, LLC Boston, MA119KShares$35,6060.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC53.7KShares$16,1200.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$8,3650.0% of portfolio
-
Ifp Advisors, Inc25KShares$7,5000.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $818K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...